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Abstract 
Background: Pulmonary oedema (PE) is a serious complication of Plasmodium falciparum malaria which can lead to 
acute lung injury in severe cases. Lung macrophages are activated during malaria infection due to a complex host-
immune response. The molecular basis for macrophage polarization is still unclear but understanding the predomi-
nant subtypes could lead to new therapeutic strategies where the diseases present with lung involvement. The 
present study was designed to study the polarization of lung macrophages, as M1 or M2 macrophages, in the lungs of 
severe P. falciparum malaria patients, with and without evidence of PE.
Methods: Lung tissue samples, taken from patients who died from severe P. falciparum malaria, were categorized 
into severe malaria with PE and without PE (non-PE). Expression of surface markers (CD68+, all macrophages; CD40+, 
M1 macrophage; and CD163+, M2 macrophage) on activated lung macrophages was used to quantify M1/M2 mac-
rophage subtypes.
Results: Lung injury was demonstrated in malaria patients with PE. The expression of CD40 (M1 macrophage) was 
prominent in the group of severe P. falciparum malaria patients with PE (63.44 ± 1.98%), compared to non-PE group 
(53.22 ± 3.85%, p < 0.05), whereas there was no difference observed for CD163 (M2 macrophage) between PE and 
non-PE groups.
Conclusions: The study demonstrates M1 polarization in lung tissues from severe P. falciparum malaria infections 
with PE. Understanding the nature of macrophage characterization in malaria infection may provide new insights into 
therapeutic approaches that could be deployed to reduce lung damage in severe P. falciparum malaria.
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Background
Pulmonary oedema (PE) is one of the major compli-
cations and therapeutic challenges in severe Plasmo-
dium falciparum malaria. This condition is associated 
with acute lung injury (ALI) and acute respiratory dis-
tress syndrome (ARDS) [1]. The incidence of ARDS in 
adults with severe P. falciparum malaria ranges from 
7.6 to 26.2% [2–5], with the mortality rate of 52.2–
89.0% [2, 5, 6]. In addition, PE occurs in approximately 
10–21% [1, 7, 8]. In P. falciparum malaria, PE is associ-
ated with inflammatory infiltrates consisting of mainly 
mononuclear cells, haemozoin deposit, the accumula-
tion of macrophages, as well as parasite sequestration 
[9]. Recruitment of macrophages to the lung signifies 
an important immune response in the pathogenesis 
of ALI/ARDS [10]. Activated macrophages have been 
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described as two functional subsets, namely classically 
activated macrophages (M1) and alternatively activated 
macrophages (M2) [11, 12]. M1 macrophages are con-
sidered as pro-inflammatory macrophages that produce 
pro-inflammatory cytokines, such as tumour necrosis 
factor (TNF), interleukin-6 (IL-6) and other mediators. 
M2 macrophages are typically anti-inflammatory mac-
rophages and produce anti-inflammatory cytokines, such 
as IL-10 and secrete growth factor such as transforming 
growth factor beta 1 (TGF-β1) for tissue repair [12].
The polarization of M1 and M2 macrophages are 
important for disease regulation. Previous studies have 
documented that activated macrophages are prominent 
in lung infection with bacteria [13] and viruses [14, 15] 
as well as in lungs from smokers and chronic obstruc-
tive pulmonary disease  (COPD) [16]. The main purpose 
of this study was to investigate the status of lung mac-
rophages, as to M1/M2 subtypes in severe P. falciparum 
malaria patients with and without PE.
Methods
Tissue specimens
Embedded human lung tissues from severe P. falcipa-
rum malaria infected patients and non-infected controls 
were retrieved from the Department of Tropical Pathol-
ogy, Faculty of Tropical Medicine, Mahidol University, 
Bangkok, Thailand. Twenty-four cases from severe P. 
falciparum malaria were originally available for evalua-
tion. Lung tissues from seven cases were inadequate for 
further studies. Of the 17 cases, they were classified into 
severe P. falciparum malaria with PE (n = 9) and non-PE 
(n = 8), according to histopathological findings. In addi-
tion, there were 6 normal lung tissues from control cases. 
Lung tissues were embedded and prepared for histo-
pathological evaluation. Based on histopathological find-
ings of oedematous fluid in the lung, lung tissues were 
divided into severe P. falciparum malaria with PE, non-
PE and control lung tissues. Normal control lung tissues 
were obtained from patients who died from accidents, 
and showed no pathological changes in the lungs. The 
study protocol was reviewed and ethical clearance was 
obtained from the Ethics Committee of Faculty of Tropi-
cal Medicine, Mahidol University (MUTM 2017-054-01).
Histopathology and evaluation
Lung tissues were re-embedded with new paraffin 
medium, sectioned at 4  μm in thickness and routinely 
stained with haematoxylin and eosin (H&E). The patho-
logical changes of lung tissues were interpreted based 
on eight histological criteria in twenty low power fields 
(LPF) (200×) per slide, namely septal congestion, alveolar 
haemorrhage, alveolar oedema, hyaline membrane for-
mation, parasitized red blood cell (PRBC) sequestration, 
malarial pigment, lung macrophages and infiltration of 
inflammatory cells [17]. Each variable was graded on a 
scale based on percentage of severity based on a previ-
ous study with modifications, as follows: no injury = 0, 
injury ≤ 25%/HPF = 1, injury > 25% and ≤ 50%/HPF = 2, 
injury > 50% and ≤ 75%/HPF = 3, and injury > 75%/
HPF = 4 [18]. Lung macrophages and white blood cells 
(WBC) were quantified and graded as follows: no cell = 0, 
cells ≤ 25/HPF = 1, cells > 25 and ≤ 50/HPF = 2, cells > 50 
and ≤ 75/HPF = 3, and cells > 75/HPF = 4. Subsequently, 
a lung injury score ranging from 0 to 32 points was cal-
culated by adding the sum of each variable to determine 
the overall histopathological changes in lung tissues from 
malaria patients with P. falciparum. A score of 0 means 
absence of histopathological changes while a score of 32 
signified the most severe histopathological changes. All 
histopathological parameters were examined in a blinded 
manner, without prior knowledge of the patients’ clinical 
status. Two independent assessors (AK, PV) evaluated 
the histopathological specimens. If there were discrep-
ancies of more than 2 grading variations, a third person 
(SG/CS) was requested to score the histopathological 
changes and the mean readings of the three assessors 
were taken.
Immunohistochemical evaluation of lung macrophages
The expressions of macrophage surface markers (CD68, 
CD40, and CD163) were detected by immunohistochem-
ical staining [19, 20]. Lung sections of 4  μm thickness 
were placed on adhesive slides coated with poly-l-ly-
sine and de-paraffinized through a series of xylene and 
re-hydrated through graded alcohol solutions. Antigen 
retrieval from lung tissues was performed by a micro-
wave technique with 0.01 mol/L citrate buffer at pH 6.0 
for 20  min. To reduce endogenous peroxidase activity, 
tissue sections were incubated with 1%  H2O2 in PBS for 
30  min at room temperature (RT) and rinsed in run-
ning tap water for 10  min. Lung sections were treated 
with normal goat serum for 30  min at RT to reduced 
non-specific background. To detect the surface makers 
on macrophages, lung sections were incubated with pri-
mary antibody: monoclonal mouse anti-human CD68 
(1:100 optimal dilution,  DakoCytomation®; Denmark), 
mouse monoclonal antibody CD163 (1:200 optimal dilu-
tion, Novocastra™; Leica Biosystems Newcastle Ltd, UK), 
and rabbit polyclonal antibody CD40 (1:200 optimal dilu-
tion, Santa Cruz Biotechnology Inc., USA) in a moisture 
chamber overnight at 4 °C. Next day, tissue sections were 
extensively washed with PBS, and incubated with sec-
ondary antibody for 30  min at RT, then incubated with 
avidin-biotin complex (ABC) conjugated with horserad-
ish peroxidase (HRP)  (VECTASTAIN® ABC Kits; Vector 
Laboratories, USA) for 30 min at RT. After the removal 
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of non-reacted secondary antibodies, all sections were 
incubated with DAB (3,3′-diaminobenzidine) Peroxi-
dase Substrate Kit (Vector Laboratories, USA) for 3 min. 
Finally, sections were counterstained with Mayer’s hae-
matoxylin, mounted with a coverslip and evaluated under 
a light microscope. Spleen was used as a positive control 
for CD68, CD40 and CD163 [21]. The anti-CD68 within 
the tissue sections were used as positive internal con-
trols. Positive cells stained brown pattern with different 
degrees of immunoreactive intensity.
Evaluation of immunohistochemistry staining
Quantitative assessments of macrophage subtypes were 
based on the number of positive stained cells for CD68, 
CD40 and CD163. Macrophages were evaluated ran-
domly in twenty fields per slide, in lung tissues and 
within the septal area under high magnification (400×). 
The numbers of surface markers specific for each mac-
rophage subtype were counted and expressed as per-
centage of positive cells. The intensity of positive stained 
cells was graded as follows: 0 = negative; 1 = weak stain-
ing; 2 = moderate staining; 3 = strong staining. The total 
score (TS) for this immunohistochemical study was 
determined by obtaining the product of the percentage 
of positive cells and the intensity of the staining [22, 23]. 
The sections were examined in a blinded manner, with-
out prior knowledge of the patients, clinical status.
Statistical analysis
All quantitative data were expressed as mean ± standard 
error of the mean (SEM). Statistical analysis was per-
formed using SPSS version 18.0 software (SPSS, USA). 
Data was tested with Kolmogorov–Smirnov test for nor-
mality of distribution. Mann–Whitney U test was used 
to analyse differences in clinical data, clinical complica-
tions and histopathological criteria between non-PE, PE 
and control groups. Difference in CD40 (M1) and CD163 
(M2) expression between groups was interpreted by one-
way analysis of variance. The correlations between total 
score of M1 expression and histological/clinical data were 
analysed by Spearman’s correlation. Statistical differences 
at p < 0.05 were considered to be statistically significant.
Results
Summary of clinical and laboratory data from malaria 
patients
The demographic data from severe P. falciparum malaria 
patients is documented in Table  1. Significant differ-
ences were observed in levels of haematocrit (p = 0.032) 
and creatinine (p = 0.023) between non-PE and PE 
groups. No significant difference in age, blood urea 
nitrogen (BUN), alanine transaminase (ALT), aspartate 
aminotransferase (AST), alkaline phosphatase (ALP), 
albumin, globulin, total bilirubin, direct bilirubin, WBC 
counts, parasitaemia and days of fever (all p > 0.05) was 
observed. Clinical adult respiratory distress syndrome 
(ARDS) and acute kidney injury were two complications 
that showed significant difference between non-PE and 
PE groups (Additional file  1: Table  S1). The causes of 
death were attributed mainly to cerebral malaria based 
on clinical manifestations and histopathological find-
ings. Usually patients died of multiple complications of P. 
falciparum malaria. No difference in other clinical com-
plications of severe malaria (cerebral malaria, jaundice/
Table 1 Clinical data of the P. falciparum malaria patients
* Significant difference of p < 0.05
Parameters Severe malaria patients (mean ± SEM) p-values
Non-PE (n = 12) PE (n = 12)
Age (years) 24.00 ± 5.09 27.00 ± 2.53 0.600
Haematocrit (%) 32.20 ± 2.91 24.00 ± 1.53 0.032*
Blood urea nitrogen (BUN) (mg/dl) 21.30 ± 3.16 51.07 ± 13.07 0.072
Creatinine (mg/dl) 1.45 ± 0.29 3.28 ± 0.72 0.023*
Alanine transaminase (ALT) (U/l) 179.33 ± 150.42 142.75 ± 10.76 0.355
Aspartate aminotransferase (AST) (U/l) 269.75 ± 193.05 133.25 ± 13.39 0.257
Alkaline phosphatase (ALP) (U/l) 75.33 ± 36.75 55.15 ± 0.57 0.133
Albumin (g/l) 2.93 ± 0.36 2.50 ± 0.26 0.375
Globulin (g/dl) 2.75 ± 0.19 3.15 ± 0.38 0.384
Total bilirubin (mg/dl) 3.33 ± 1.75 6.87 ± 3.82 0.467
Direct bilirubin (mg/dl) 8.09 ± 4.13 12.08 ± 6.21 0.630
White blood cell (WBC) (/µl) 25,291 ± 15,400 25,200 ± 12,947 0.101
Parasitaemia/µl on admission 401.00 ± 369.95 93.50 ± 56.28 0.485
Days of fever 3.25 ± 0.52 4.33 ± 0.92 0.418
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hepatic dysfunction, severe anaemia, severe metabolic 
acidosis, hypoglycaemia, shock and disseminated intra-
vascular coagulopathy) was observed between the two 
groups (Additional file 1: Table S1).
Histopathological changes in the lungs of P. falciparum 
malaria patients
Common histopathological changes in the lungs of 
severe P. falciparum malaria included the presence of 
septal congestion and alveolar haemorrhage (Fig.  1a), 
alveolar oedema (Fig.  1b), hyaline membrane formation 
(Fig.  1c), PRBC sequestration in pulmonary capillaries 
(Fig. 1d), malarial pigment and an increase in the num-
ber of macrophages in alveolar spaces and septal area 
(interstitial area) (Fig. 1e) (all p < 0.05, compared to con-
trol lung, Fig. 1f ). Mixed inflammatory cells are occasion-
ally seen within the alveoli. Comparing non-PE and PE 
groups, significant difference in histological findings were 
noted in the presence of alveolar haemorrhage, alveolar 
oedema, accumulation of malarial pigment and the num-
ber of lung macrophages (all p < 0.05). The calculated 
lung injury score (based on histopathological criteria) 
was significantly higher in both the non-PE and the PE 
group, compared to control group (all p = 0.001, Addi-
tional file  2: Table  S2). Moreover, the lung injury score 
was significantly higher in PE group (19.67 ± 0.88), com-
pared to non-PE group (12.75 ± 0.75, p = 0.001) (Fig. 2). 
Other non-lung histopathological findings are listed in 
Table 2. Acute tubular necrosis was more prevalent in PE 
group compared to non- PE group (p = 0.038).
d fe
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Fig. 1 Histopathological changes of lungs in P. falciparum malaria: a alveolar congestion and haemorrhage (asterisks), b alveolar oedema (asterisks), 
c hyaline membrane formation in alveolar wall (arrows), d sequestration of PRBCs (arrows), e malarial pigment laden macrophages in septal area 
(asterisks) and in alveolar spaces (arrows), f normal lung from control sample (Images a ×200, b, c and f ×100, d and e ×400)
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Fig. 2 Lung injury score in malaria patients. A significant difference 
was observed between PE and non-PE (p < 0.05). Data presented as 
mean ± SEM
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Immunohistochemistry study of M1/M2
Expression of CD68
CD68 expressing cells were detected as fine brown color 
in the cytoplasm of lung macrophages in both the sep-
tal area and within the alveoli (Fig.  3a). The number of 
macrophage positive cells was significantly increased 
in PE group (49.23 ± 5.16/HPF) compared to the non-
PE group (31.22 ± 3.81/HPF, p = 0.016) and the normal 
control group (6.40 ± 1.39/HPF, p = 0.001). In septal 
areas, no significant difference in CD68 positive cells 
was noted between PE (36.64 ± 4.50/HPF), and non-PE 
groups (24.41 ± 3.40/HPF, p = 0.118). However, both 
malaria groups showed significantly higher CD68 posi-
tive cells compared to the control group (3.58 ± 0.99/
HPF, p < 0.05).
Expression of CD40
CD40 was used to detect activated M1 subtype lung mac-
rophages. Positive cells expressed a fine brown color on 
the cell membrane of macrophages. The relative expres-
sion of CD40 was prominent in the group of severe P. 
falciparum malaria with PE (63.44 ± 1.98%) compared to 
non-PE (53.22 ± 3.85%, p = 0.018) and the control group 
(43.59 ± 2.61%, p < 0.01) (Figs.  3b, 4a). Macrophages 
expressing CD40 in the alveolar septal area between PE 
and non-PE groups showed similar trends as in the lung 
tissues, as depicted in Fig. 4a.
Expression CD163
CD163 was used as a marker for the M2 subtype. Posi-
tive cells express a fine brown color in the cytoplasm of 
macrophages. Lung macrophages in severe P. falcipa-
rum malaria patients with PE showed a relative decrease 
CD163 expression, compared to the control group 
(p < 0.024). No significant difference in the mean percent-
age of CD163 positive cells was observed between PE 
and non-PE groups (p = 0.075), and between non-PE and 
control groups (p = 0.493). In addition, no significant dif-
ference in CD163 expression in the septal area was noted 
among three groups (p > 0.05) (Figs. 3c, 4b).
Correlations between M1 total score and histopathological 
changes
There was a significant positive correlation between 
the total score of CD40 expression (M1) and alveolar 
haemorrhage (rs = 0.614, p = 0.002), alveolar oedema 
(rs = 0.538, p = 0.008), the number of lung macrophages 
(rs = 0.465, p = 0.025), WBC infiltration (rs = 0.463, 
p = 0.026) and acute lung injury score (rs = 0.652, 
p = 0.001) (Fig.  5a–e). Due to the distribution of vari-
ables, correlation analysis was unsuitable to perform for 
septal congestion, hyaline membrane formation, PRBC 
sequestration and presence of malaria pigments.
Discussion
Acute lung injury (ALI) was demonstrated in severe P. 
falciparum malaria patients, with more severe changes 
in patients with pulmonary oedema (PE). The pathologi-
cal findings of septal congestion, alveolar haemorrhage, 
alveolar oedema, hyaline membrane formation, malarial 
pigment, increase number of lung macrophages (both 
alveolar and interstitial), and white blood cells are com-
monly seen in lung tissues of fatal P. falciparum malaria, 
in addition to the presence of PRBCs.
PE is a common finding in ALI and can cause the 
lungs to develop into acute respiratory distress syn-
drome (ARDS) [24]. The activation of lung mac-
rophages and release of cytokines are important 
mechanisms contributing to lung damage in patients 
with ARDS [19, 25]. Under various triggers, lung 
macrophages can be polarized into either classically 
activated (or M1) or alternatively activated (or M2) 
subtypes [26]. M1 macrophages can be stimulated by 
interferon (IFN)-γ, lipopolysaccharide (LPS) and granu-
locyte–macrophage colony stimulating factor, causing 
upregulation of genes involved in pathogen clearance 
and an inflammatory response. M2 macrophages, on 
the other hand, are induced by interleukin (IL)-4 and IL 
13 and cause upregulation of genes involved in wound 
healing, phagocytic activity and an anti-inflammatory 
responses [26]. The main secreting cytokines from 
M1 macrophages which contribute to ALI include 
tumour necrosis factor (TNF), IL-1β and reactive oxy-
gen species [27]. In malaria, an essential factor that 
Table 2 Non-lung histopathological findings of P. falciparum 
malaria patients
*Significant difference of p < 0.05
Non-lung histopathological findings Non-PE PE p-values
Brain (n = 10) (n = 12)
 PRBC sequestration 7 9 0.798
 Petechial/ring haemorrhages 8 9 0.785
Heart (n = 10) (n = 9)
 PRBC sequestration 7 6 0.879
Liver (n = 12) (n = 11)
 Kupffer cell proliferation 12 11 1.000
 Haemozoin deposit 10 10 0.598
 PRBC sequestration 9 10 0.325
Kidney (n = 10) (n = 9)
 Mesangial proliferations 5 5 0.814
 Protein deposition in Bowman’s space 1 3 0.225
 PRBC sequestration 7 8 0.326
 Haemozoin deposit 8 8 0.606
 Acute tubular necrosis 1 5 0.038*
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can contribute to the pathogenesis of lung injury is 
haemozoin pigment present in the lung tissue. A previ-
ous study in an animal model reported that haemozoin 
pigment can activate pro-inflammatory mediators and 
is related to the occurrence of ARDS in mice [28]. The 
subsequent influx of inflammatory cells into the lung 
tissue damages endothelial cells and results in increased 
vascular permeability [29]. It is possible that haemo-
zoin activated pro-inflammatory chemokines (i.e., 
IFN-γ, CXCL 10), and cytokines (i.e., TNF, IL-6) [30] 
can contribute to M1 polarization in malaria, result-
ing in ALI/ARDS. Consequently, pathological changes 
Non-PE
a
CD68? bCD40? cCD163?
Control 
PE
Fig. 3 The immunohistochemical staining of lung macrophages in P. falciparum malaria. Expressions of CD68 (a), CD40 (b), and CD163 (c), were 
demonstrated in control, non-PE and PE groups. CD68 expression showed fine brown color in the cytoplasmic granules. CD40 expression was 
evident on cell membrane while CD163 positive cells showed fine brown color in the cytoplasm of lung macrophages. (All images: ×400, Avidin–
Biotin–peroxidase complex technique)
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Fig. 4 Comparative mean percentages of lung macrophage positive cells for CD 40 (a) and CD 163 (b) of control, non-PE and PE groups
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of PE, pulmonary haemorrhage, further recruitment of 
inflammatory cells and hyaline membrane formation 
may occur. In addition, macrophages can adhere and 
interact with the epithelium of alveoli resulting in an 
increase in cytosolic calcium levels which can lead to 
apoptosis of epithelial cells and the release of TNF. This 
mechanism can further damage the pulmonary barrier 
resulting in PE [25].
Malaria infection triggers recruitment of resident 
macrophages to the lungs as evident by an increase in 
CD68 expressing cells. Results demonstrated the accu-
mulation of M1 macrophages in the lung of severe P. 
falciparum malaria patients, especially in the PE group 
as demonstrated by an increase in CD40 expressing 
cells. Similar findings were documented in mice lung 
infected with Escherichia coli [31], in lung-induced 
chronic obstructive pulmonary disease (COPD) [16], 
and in viral infection in mice [14]. In addition to M1 
being associated with accumulation of haemozoin 
and the occurrence of acute lung injury, polarization 
of macrophages to the M1 subtype is responsible for 
controlling infectious diseases during the acute phase. 
In influenza virus infection, lung macrophages can 
polarize to M1 in the early stage and later present the 
M2b phenotype. Functionally, M1 macrophages are 
characterized by enhanced endocytic functions and 
enhanced ability to kill intracellular pathogens [32]. 
In Listeria monocytogenes infection, M1 macrophages 
were reported to be activated. These macrophages help 
prevent bacterial phagosome escape and stimulate 
intracellular killing of bacteria [31].
From this study, M1 (CD40) macrophages predominate 
in the PE group and correlate directly with lung pathol-
ogy, providing evidence for M1 associated damaged lung 
tissue in severe P. falciparum malaria. M2 polarization 
(CD163) however, was similar in both the PE and non-
PE group. It would be optimal to simultaneously ana-
lyse the expressions of CD68, CD40 and CD163 in lung 
macrophages by incorporating these three antigens and 
their co-expression on a single lung tissue. Thus, avoiding 
certain non-specific staining that could interfere with the 
analysis. In addition to the limitation on staining tech-
nique used, it is important to note that evaluating anti-
gen expressions in the lung tissues from different groups 
could not be entirely blinded. Although, assessors were 
unaware of the clinical groups and were provided with 
blind-coded lung tissue slides; the presence of fluid in the 
alveoli could somehow create an unavoidable bias during 
microscopic evaluation.
Previous reports documented an increase CD163 lev-
els in uncomplicated malaria patients as compared to 
severe malarial anaemia and cerebral malaria patients. 
This phenomenon is suggestive of a higher-level anti-
inflammatory response in uncomplicated malaria in 
order to avoid disease complications [33]. Since lung 
samples from this study was available only once, at 
autopsy, no data on sequential M1/M2 shifts between 
early and late infection in human malaria is possible. 
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Page 8 of 9Klinkhamhom et al. Malar J          (2020) 19:182 
Theoretically, at a later stage of malaria infection, after 
pathogenic factors are eliminated through therapeu-
tic anti-malarial treatment and immune clearance of 
malaria parasites, lung macrophages may shift from a 
M1 phenotype to the anti-inflammatory M2 phenotype. 
The switching of macrophage polarity has been associ-
ated with transcriptional control [34]. M2 macrophages 
have an important role in lung tissue repair by limiting 
the levels of proinflammatory cytokines in the cellular 
space and producing anti-inflammatory cytokines such 
as IL-10 and IL-1 receptor antagonist [10]. M2 mac-
rophages also remove necrotic cells and debris through 
phagocytic activity, which can be demonstrated in 
the malaria lung tissues as lung macrophages engulf 
haemozoin and fragmented PRBCs.
Conclusions
Pulmonary macrophages are believed to be an important 
factor in causing lung pathology in malaria. The study 
showed M1 macrophage activation in ALI in severe P. fal-
ciparum malaria, which indicates disease severity. As M1 
polarization prevails, more lung damage can occur. Fur-
ther investigation on the pathways of the malaria-induced 
M1 phenotype is necessary to identify specific activators 
for M1 polarization that could be attenuated and factors 
that promote the anti-inflammatory M2 phenotype, in 
order to suppress the inflammation and improve clinical 
ALI in severe malaria patients.
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